the European Institute of Oncology
Published by:
Education
Key Advances in Clinical Practice Series
It won't be long before all professionals involved in cancer care and research will be required to complete continuous professional courses in some shape or form.
We are delighted to announce a collaboration with the UK Key Advances in Clinical Practice Series. A series of symposia and masterclasses run in association with King's College London aimed at discussing currently available scientific evidence and expert clinical opinion for the prevention, investigation and management of different cancers.
The Key Advances educational programmes are webcast on ecancermedicalscience and are available to watch, free of charge, at any time.
Key Advances in the Effective Management of Thyroid Cancer
This meeting was supported by GE Healthcare. GE Healthcare had no involvement in the agenda or production of the presentations.
| Speaker | Subject |
| Ms Kate Farnell | Patient and public involvement in clinical decision making and service planning |
| Dr Sue Clarke | PET scanning: Does it have a role? |
| Mr Bill Fleming | Surgical Dilemas: The conservative approach |
| Mr David Scott-Coombes | Complications and long term morbidity |
| Mr Barney Harrison | Medullary carcinoma: A conservative or aggressive approach? |
| Dr Musad Haq | 20 year follow up of patients treated by low activity 131I ablation |
| Dr Georgina Gerrard | The national BTA/RCP guidelines: Where are we now? |
| Dr Ujjal Mallick | The enigma of thyroglobulin +ve/131I-negative patients HiLo: The national UK prospective trial |
Key Advances in the Effective Management of Head and Neck Cancer
This meeting was supported by Merck Serono. Merck Serono had no involvement in the agenda or production of the presentations.
| Speaker | Subject |
| Mr Graham Cox | Diagnosis and assessment of lymphadectomy in the neck |
| Mr Terry Jones | Diet and its role in surgical outcome |
| Dr Mehmet Sen | Current advances in chemoradiation for locally advanced head and neck cancer |
| Mr Richard Shaw | Molecular profiling of head and neck cancers - how close are we to predicting the best therapeutic intervention? |
| Professor Gordon Proctor | Pathophysiology, assessment and potential therapeutic options in radiation-induced xerostomia |
| Professor Michelle Saunders | Current status of altered fractionation in locally advanced head and neck cancer |
We will soon direct the community to forthcoming educational initiatives and programmes to be launched by our Founding Partner, ECCO - the European CanCer Organisation. This will enable us to jointly offer a comprehensive choice of educational materials for surgeons, nurses, physicians, radiation specialists, and technologists, general practitioners, counsellors and advocates of cancer care.
